13.00 – 14:00 FUTURE LEADERS MENTORING: WARMING UP
Chairs: S. Aliberti, J. D. Chalmers
Session dedicated to the Hungarian Interns in Respiratory Medicine   
 14.00 – 15.00 RISING STAR SESSION
Chairs: F. Blasi, G.W. Canonica, S. Centanni, T. Welte, J.C. Virchow
Each lecture will be followed by 10’ question time and 5’ of comments and advices by the Chairmen.
 14.00 – 14.15 The role of bronchodilation on airway mechanical stress, lung hyperinflation and NO production in stable COPD
Dejan Radovanovic (Italy / Croatia) 
 14.30 – 14.45 Using Optical Coherence Tomography to evaluate airway dynamics in vivo
Margit Szabari (Hungary)
Each lecture will be followed by 10’ question time and 5’ of comments and advices by the Chairmen
 15.00 – 15.30 OPENING LECTURE
Chair: J.C. Virchow (Germany),  I. Horváth (Hungary)
Toward precision medicine of chronic respiratory diseases  (1) 
Stephen Holgate (UK)
 15.45 – 16.45 INDUSTRY SPONSORED SYMPOSIUM
 16:30 – 17.00 COFFEE BREAK
 17.00 – 18.50   SESSION 1: Bronchiectasis: from surveys and registries to management changes
Chairs: F. Blasi (Italy), A. Torres (Spain)
 17.00 – 17.30 From surveys to EMBARC: international collaborations in bronchiectasis
James D. Chalmers (UK) 
 17.30 – 18.00 Phenotyping bronchiectatic patient: is it feasible/useful?
Eva Polverino (Spain)
 18.00 – 18.30 Are RCT useful in the real life management of bronchiectasis?
Tobias Welte (Germany)  
 18:30 – 18:50 Discussion
 18.50 – 19.30  INDUSTRY SPONSORED KEYNOTE LECTURE
 19.30 – 20.30 OPENING RECEPTION
(1)  Lecture included in the “Future Leaders Mentoring” programme
 08.30 – 09.15 KEYNOTE LECTURE
Chair: G. W. Canonica (Italy)
Eosinophilic airway inflammation in asthma and COPD (1)
Guy Brusselle (Belgium)
 09.15 – 10.50 SESSION 2. NEW KIDS ON THE BLOCK
Chairs: M. Gaga (Greece), S. Centanni (Italy)
 09.15 – 09.35 Idiopathic Pulmonary Fibrosis
Luca Richeldi (Italy / UK) 
 09.35 – 09.55 Cystic Fibrosis
Stuart J. Elborn (UK)
 09.55 – 10.15 Severe Asthma
Giorgio Walter Canonica (Italy) 
 10.15 – 10.35 Pneumonia
Tobias Welte (Germany)  
 10.35 – 10.50 Discussion 
 10.50 – 11.20 COFFEE BREAK
 11.20 – 12.30 SESSION 3. NEW APPROACHES TO ALLERGY AND ASTHMA: IMMUNOTHERAPY
Chairs: S. Bonini (Italy), T. Welte (Germany)
 11.20 – 11.50 Allergy and Asthma Immunotherapy: State of the Art 
Johann Christian Virchow (Germany)
 11.50 – 12.20 New treatments on the blocks
Fulvio Braido (Italy)  
 12.20 – 12.30 Discussion 
 12.30 – 13.30   INDUSTRY SPONSORED SYMPOSIUM
 13.30 – 14.30 LUNCH
 14.30 – 15.45 SESSION 4. COPD EXACERBATIONS: HOW  TO PREVENT, HOW TO TREAT
Chairs: S. Aliberti (Italy), J.D. Chalmers (UK)
 14.30 – 14.50 Inhaled drugs: are we preventing different exacerbations ? (1)
Emil Wouters (Netherlands)
 14.50 – 15.10 Antibiotics can help 
Antoni Torres (Spain)
 15.10 – 15.30 Beyond NIV
Alberto Zanella (Italy) 
 15.30 – 15.45 Discussion
 15.45 – 16.15 KEYNOTE LECTURE
Chair: Alberto Papi (Italy)
From full lung treatment to improving outcomes for COPD patients (1)
Omar Usmani (United Kingdom)
 16.15 – 16.45 COFFEE BREAK
 16.45 – 18.00 SESSION 5. COPD RECOMMENDATIONS: ARE WE SPEAKING THE SAME LANGUAGE?
Chairs: F. Di Marco (Italy), C. Robalo – Cordeiro (Portugal)
 16.45 – 17.15 The European recommendations: from the Atlantic to the Ural Mountains
Francesco Blasi (Italy) 
 17.15 – 17.45 GOLD Recommendations
Roberto Rodriguez-Roisin (Spain) 
 17.45 – 18.00 Discussion
  (1)  Lecture included in the “Future Leaders Mentoring” programme
 08.00 – 09.00 POSTER SESSIONS
Chairman: F. Blasi, G.W. Canonica, S. Centanni, T. Welte
 09.00 – 09.30 KEYNOTE LECTURE
Chair: T. Welte (Germany)
Pulmonary Rehabilitation: from COPD to lung transplantation
Pierachille Santus (Italy) 
 09.30 – 11.10 SESSION 6: STABLE COPD TREATMENT: ALGORITHMS, GUIDELINES OR COMMON SENSE?
Chair: S. Centanni (Italy)
 09.30 – 09.50 Bronchodilator mono or dual therapy : when, how, for whom
Mario Cazzola (Italy)
 09.50 – 10.10 LABA/ICS: when, how, for whom
Nicolas Roche (France) 
 10.10 – 10.30 Triple therapy: the end of the story?
Alberto Papi (Italy)
 10.30 – 10.50 New devices, new technologies: from the patient side
Federico Lavorini (Italy) 
 10.50 – 11.10 Discussion
 11.10 – 11.30 COFFEE BREAK
 11.30 – 12.00 KEYNOTE LECTURE
Chair: V. Brusasco (Italy)
Biological drugs: a new target therapy in COPD?
Chris Brightling (UK)  
 12.00 – 12.30 POSTER AWARDS & CLOSING REMARKS
Chairman: F. Blasi, G.W. Canonica, S. Centanni, T. Welte
12.30 – 13:30 FUTURE LEADERS MENTORING: REPORT AND FEEDBACK
Chairs: S. Aliberti, J.D. Chalmers
Session where the Hungarian Interns will report on the outcome of their mentoring programme. Session open to all participants.
DISCLAIMER: THE FOLLOWING SESSIONS ARE ORGANIZED BY INDUSTRY.
YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS
Thursday , 19 January 2017
 15.30 – 16.30 SYMPOSIUM: ASTHMA IN REAL LIFE
SPONSORED BY MENARINI
 15.30 – 15.35  Introduction 
G.W. Canonica (Italy)
 15.35 – 15.50  Real life management of disease and inhalation therapy
Pierluigi Paggiaro (Italy)  
 15.50 – 16.05  Speed and efficacy for 24 hours: the key factors for the management of asthma patients in real life 
Fulvio Braido (Italy) 
 16.05 – 16.20  Vilanterol / Fluticasone Furoate  
Girolamo Pelaia (Italy)  
 16.20 – 16.30  Conclusions  
G.W. Canonica (Italy)
 18.50 – 19.30 KEYNOTE LECTURE
SPONSORED BY GRIFOLS
Chair: James D. Chalmers (UK)
Management of NCFBE patients colonized with Pseudomonas Aeruginosa
Stefano Aliberti (Italy) 

DISCLAIMER: THE FOLLOWING SESSIONS ARE ORGANIZED BY INDUSTRY.
YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS
Friday, 20 January 2017
 12.30 – 13.30 SPONSORED SESSION NEW PARADIGMS IN PATIENT NEEDS, NEW SOLUTIONS
Chairs: S. Centanni (Italy), N. Roche (France)
LECTURE SPONSORED BY LABORATORI GUIDOTTI – MALESCI ISTITUTO FARMACOBIOLOGICO
12.30 – 12.50 What the COPD patient wants
Fabiano Di Marco (Italy)
LECTURE SPONSORED BY LABORATORI GUIDOTTI – MALESCI ISTITUTO FARMACOBIOLOGICO
12.50 – 13.10 New therapy options to meet the patients’ needs
Pierachille Santus (Italy)
LECTURE SPONSORED BY ASTRAZENECA  
13.10 – 13.30   The importance of the device to the patients’ quality of life  
Fulvio Braido (Italy)